Jacobs Levy Equity Management, Inc Cytek Biosciences, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $24.2 Billion
- Q2 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 888,339 shares of CTKB stock, worth $3.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
888,339
Previous 708,482
25.39%
Holding current value
$3.42 Million
Previous $2.84 Million
6.3%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CTKB
# of Institutions
156Shares Held
74MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$65.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$29.9 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.11MShares$27.4 Million0.72% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$25.6 Million0.93% of portfolio
-
State Street Corp Boston, MA4.17MShares$16.1 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $518M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...